1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 11 MAY 2015

Cancer Drug News 11 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Diversification To Bolster Celgene's Revenues
Industry Brief - Roche's Venetoclax Gains FDA Breakthrough Therapy Designation
Industry Trend Analysis - Zykadia Will Not Surpass Xalkori Without First-Line Approval
Industry Brief - ESSA's IND Application For EPI-506 Placed On Clinical Hold By FDA
Industry Brief - FDA Grants ODD To Oncolytics' Reolysin For Gastric Cancers
Industry Brief - Baxter Seeks EU Approval For MM-398 In Post-Gemcitabine MPC
Industry Brief - Can-Fite's CF102 Phase II HCC Trial Approved In Europe
Industry Trend Analysis - CytRx' Outperformance To Continue
Industry Brief - Plexxikon/Merck Collaborate On PLX3397/Keytruda Combination Trial
Industry Brief - COT Granted European Patent Covering COTI-2
Industry Brief - Qu Biologics Granted EU Patent Covering Use Of Bacterial Compositions In Cancer
Industry Brief - Acacia Reports Positive Results From Phase II Study With APD403 In CINV
Industry Brief - FDA Grants Fast Track Designation To Sucampo's Cobiprostone
Industry Trend Analysis - EpiTherapeutics Acquisition Will Be Start Of Oncology Deals For Gilead In 2015

Table Of Contents

Cancer Drug News 11 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Cancer and Breast Cancer Statistics in Switzerland

  • February 2017
    138 pages
  • Cancer  

    Breast Cancer  

    Obesity  

  • Switzerland  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Endocrine Disease Statistics in the US

  • February 2017
    115 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Cancer Statistics

5 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.